Chun‐Ming Wong

14.4k citations

130 papers · 9.6k indexed · 4 hit papers · h-index 51

Impact in

Cancer Research top 0.2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
Molecular Biology top 0.5%
- RNA modifications and cancer
- Cancer-related gene regulation
- Epigenetics and DNA Methylation
- Circular RNAs in diseases
- RNA Research and Splicing

Papers in

Cancer Research 48
- Cancer, Hypoxia, and Metabolism 20
- Cancer-related molecular mechanisms research 18
- MicroRNA in disease regulation 13
Chemical Health and Safety 1

Co-authors: Irene Oi‐Lin Ng Carmen Chak‐Lui Wong Felice Ho‐Ching Tsang Joyce Man‐Fong Lee David Kung‐Chun Chiu Mengnuo Chen Cheuk‐Ting Law Lai Wei
Journals: Hepatology (17 papers)Cancer Research (9 papers)Journal of Hepatology (6 papers)PLoS ONE (5 papers)Nature Communications (4 papers)
Partner nations: Hong Kong China United States

In The Last Decade

Chun‐Ming Wong

123 papers receiving 9.5k citations

Hit Papers

align trajectories log scale

Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC 2019 · 297 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 Nature Communications
2018 Nature Reviews Gastroenterology & Hepatology
2017 Hepatology
2011 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Chun‐Ming Wong

Since Specialization

Citations

This map shows the geographic impact of Chun‐Ming Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun‐Ming Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun‐Ming Wong more than expected).

Fields of papers citing papers by Chun‐Ming Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun‐Ming Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun‐Ming Wong. The network helps show where Chun‐Ming Wong may publish in the future.

Co-authors

The 25 scholars most cited alongside Chun‐Ming Wong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chun‐Ming Wong Line = papers co-authored together Chun‐Ming Wong links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Genome-wide CRISPR Screening Identifies NFκB and c-MET as Druggable Targets to Sensitize Lenvatinib Treatment in Hepatocellular Carcinoma Cellular and Molecular Gastroenterology and Hepatology ·T.S.K. Wan, Wen-Sen Lai, Cheng Li, Wai Chin, Jun Shen, For-Fan Chan, Zhijian Kuang, Cun Wang, Carmen Chak-Lui Wong, Chun‐Ming Wong	2025	0
2	ETV5-S100A9 feed-forward loop connecting HCC and MDSCs to shape the immunosuppressive tumour microenvironment Gut ·Carmen Chak‐Lui Wong, Chun‐Ming Wong	2025	1
3	Targeting the oncogenic m6A demethylase FTO suppresses tumourigenesis and potentiates immune response in hepatocellular carcinoma Gut ·Ao Chen, Xin Zhang, Qingyang Zhang, Karen Man‐Fong Sze, Lü Tian, Hongyang Huang, Xia Wang, Eva Lee, Jingyi Lu, Xueying Lyu, M. Lee, Chun‐Ming Wong, Daniel Wai‐Hung Ho, Irene Oi‐Lin Ng	2024	41
4	Acupuncture combined with auricular acupressure for smoking cessation and its effects on tobacco dependence and smoking behavior among Hong Kong smokers: a multicenter pilot clinical study Chinese Medicine ·Lai Fun Ho, Wai Kwan Ho, Beatrix Wong, Sze Wan Chiu, Shuk Yu Tang, Chun‐Ming Wong, Kin San Chan, Chi Lan Lam, Min Chen, Kam Leung Chan, Guohua Lin, Bacon Fung Leung Ng, Zhi Xiu Lin	2022	6
5	RSK2-inactivating mutations potentiate MAPK signaling and support cholesterol metabolism in hepatocellular carcinoma Journal of Hepatology ·Lo‐Kong Chan, Daniel Wai‐Hung Ho, Charles Shing Kam, Elley Yung-Tuen Chiu, Irene Lo, Derek Yau, Elaine Cheung, C N Tang, Victor Wai-Lun Tang, Terence K. Lee, Carmen Chak‐Lui Wong, Ksh Chok, Albert Chan, Tan To Cheung, Chun‐Ming Wong, Irene Oi‐Lin Ng	2020	38
6	Histone chaperone FACT complex mediates oxidative stress response to promote liver cancer progression Gut ·Jialing Shen, Mengnuo Chen, Derek Lee, Cheuk‐Ting Law, Lai Wei, Felice Ho‐Ching Tsang, Don Wai‐Ching Chin, Carol Lai‐Hung Cheng, Joyce Man‐Fong Lee, Irene Oi‐Lin Ng, Carmen Chak‐Lui Wong, Chun‐Ming Wong, (unknown), (unknown)	2019	42
7	NDUFA4L2 Fine-tunes Oxidative Stress in Hepatocellular Carcinoma Clinical Cancer Research ·Robin Kit‐Ho Lai, Mingjing Xu, David Kung‐Chun Chiu, Aki Pui‐Wah Tse, Larry Lai Wei, Cheuk‐Ting Law, Derek Lee, Chun‐Ming Wong, Maria Pik Wong, Irene Oi‐Lin Ng, Carmen Chak‐Lui Wong	2016	69
8	TSC1/2 mutations define a molecular subset of HCC with aggressive behaviour and treatment implication Gut ·Daniel Wai‐Hung Ho, Lo‐Kong Chan, Yung Tuen Chiu, Mingjing Xu, Ronnie T. P. Poon, Tan To Cheung, Chung Ngai Tang, Victor Tang, Irene Lo, Polly W.Y. Lam, Derek Yau, Miao X Li, Chun‐Ming Wong, Irene Oi‐Lin Ng	2016	87
9	Health of catering workers in Hong Kong: impact of the 2006 tobacco control legislation. PubMed ·A J Hedley, SM McGhee, R Fielding, James Repace, Chun‐Ming Wong, Songyi Lu, Aly Ho, HK Lai, L C Wong, Jing Chen	2014	0
10	Switching of Pyruvate Kinase Isoform L to M2 Promotes Metabolic Reprogramming in Hepatocarcinogenesis PLoS ONE ·Carmen Chak‐Lui Wong, Sandy Leung–Kuen Au, Aki Pui‐Wah Tse, Mingjing Xu, Robin Kit‐Ho Lai, David Kung‐Chun Chiu, Larry Lai Wei, Dorothy Ngo-Yin Fan, Felice Ho‐Ching Tsang, Regina Cheuk‐Lam Lo, Chun‐Ming Wong, Irene Oi‐Lin Ng	2014	66
11	Epigenetic dysregulation in hepatocellular carcinoma: focus on polycomb group proteins Frontiers of Medicine ·Sandy Leung–Kuen Au, Irene Oi‐Lin Ng, Chun‐Ming Wong	2013	20
12	SERPINA5 inhibits tumor cell migration by modulating the fibronectin‐integrin β1 signaling pathway in hepatocellular carcinoma Molecular Oncology ·Ying Jing, Deshui Jia, Chun‐Ming Wong, Irene Oi‐Lin Ng, Zhenfeng Zhang, Li Liu, Qifeng Wang, Fangyu Zhao, Jinjun Li, Ming Yao, Xing Wu, Xianghuo He	2013	35
13	Histone Lysine Methyltransferase, Suppressor of Variegation 3-9 Homolog 1, Promotes Hepatocellular Carcinoma Progression and Is Negatively Regulated by MicroRNA-125b Hepatology ·Dorothy Ngo-Yin Fan, Felice Ho‐Ching Tsang, Aegean Hoi-Kam Tam, Sandy Leung–Kuen Au, Carmen Chak‐Lui Wong, (unknown), Lai Wei, Joyce Man‐Fong Lee, Xianghuo He, Irene Oi‐Lin Ng, Chun‐Ming Wong	2012	95
14	Sequential alterations of microrna expression in hepatocellular carcinoma development and venous metastasis Hepatology ·Chun‐Ming Wong, Carmen Chak‐Lui Wong, Joyce Man‐Fong Lee, Dorothy Ngo-Yin Fan, Sandy Leung–Kuen Au, Irene Oi‐Lin Ng	2011	90
15	The MicroRNA miR-139 Suppresses Metastasis and Progression of Hepatocellular Carcinoma by Down-regulating Rho-Kinase 2 Gastroenterology ·Carmen Chak‐Lui Wong, Chun‐Ming Wong, Edmund Kwok–Kwun Tung, Sandy Leung–Kuen Au, Joyce Man‐Fong Lee, Ronnie Tung‐Ping Poon, Kwan Man, Irene Oi‐Lin Ng	2010	254
16	RhoGTPases and Rho-effectors in hepatocellular carcinoma metastasis: ROCK N' Rho move it Liver International ·Carmen Chak‐Lui Wong, Chun‐Ming Wong, Sandy Leung–Kuen Au, Irene Oi‐Lin Ng	2010	36
17	Hepatitis B Virus–Associated Multistep Hepatocarcinogenesis: A Stepwise Increase in Allelic Alterations Cancer Research ·Joyce Man‐Fong Lee, Chun‐Ming Wong, Irene Oi‐Lin Ng	2008	29
18	Molecular pathogenesis of hepatocellular carcinoma Liver International ·Chun‐Ming Wong, Irene Oi‐Lin Ng	2007	126
19	Rho GTPase-Activating Protein Deleted in Liver Cancer Suppresses Cell Proliferation and Invasion in Hepatocellular Carcinoma Cancer Research ·Chun‐Ming Wong, Judy Wai Ping Yam, Ching C. Lau, Tai-On Yau, Thomas Leung, Dong‐Yan Jin, Irene Oi‐Lin Ng	2005	174
20	Uterine argidase inhibition affect the rat embryonic development Contraception ·José D. Méndez, Ricardo Yañez, Chun‐Ming Wong, J J Hicks	1986	12

About Chun‐Ming Wong

Chun‐Ming Wong is a scholar working on Cancer Research, Chemical Health and Safety, Molecular Biology, Health, Toxicology and Mutagenesis and Oncology, having authored 130 papers that have together received 9.6k indexed citations. Recurring topics across this work include RNA modifications and cancer (30 papers), Cancer, Hypoxia, and Metabolism (20 papers), Cancer-related molecular mechanisms research (18 papers), Epigenetics and DNA Methylation (17 papers), MicroRNA in disease regulation (13 papers), Cancer-related gene regulation (11 papers), Air Quality and Health Impacts (8 papers) and Cancer-related Molecular Pathways (8 papers). The work is most often cited by research in Cancer Research (4.0k citations), Molecular Biology (6.7k citations), Hepatology (633 citations), Oncology (1.6k citations) and Immunology (839 citations). Chun‐Ming Wong has collaborated with scholars based in Hong Kong, China and United States. Frequent co-authors include Irene Oi‐Lin Ng, Carmen Chak‐Lui Wong, Felice Ho‐Ching Tsang, Joyce Man‐Fong Lee, David Kung‐Chun Chiu, Mengnuo Chen, Cheuk‐Ting Law, Lai Wei, Sandy Leung–Kuen Au and Xiao Dong Chen. Their work appears in journals such as Hepatology, Cancer Research, Journal of Hepatology, PLoS ONE and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact